C07D 207/327
Radicals substituted by carbon atoms having three bonds to hetero atoms with
Official title: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D207/327 (Radicals substituted by carbon atoms having three bonds to hetero atoms with) appears on 208 US grants and 165 published applications in this corpus.
Search patents in C07D- Granted patents
- 208
- Published applications
- 165
- Assignees
- 138
- Inventors
- 710
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 5 | 0 |
| 1979 | 11 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 5 | 0 |
| 1995 | 6 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 6 | 0 |
| 2002 | 5 | 3 |
| 2003 | 5 | 6 |
| 2004 | 5 | 10 |
| 2005 | 2 | 1 |
| 2006 | 0 | 7 |
| 2007 | 3 | 11 |
| 2008 | 6 | 16 |
| 2009 | 4 | 9 |
| 2010 | 7 | 13 |
| 2011 | 8 | 13 |
| 2012 | 12 | 8 |
| 2013 | 7 | 6 |
| 2014 | 13 | 8 |
| 2015 | 8 | 8 |
| 2016 | 3 | 3 |
| 2017 | 9 | 4 |
| 2018 | 2 | 6 |
| 2019 | 5 | 5 |
| 2020 | 3 | 6 |
| 2021 | 4 | 2 |
| 2022 | 4 | 7 |
| 2023 | 2 | 2 |
| 2024 | 3 | 3 |
| 2025 | 1 | 5 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications9 Jun 2026US 12,649,712 B2NucMito Pharmaceuticals Co. Ltd.
- EBNA1 inhibitors and their method of use25 Mar 2025US 12,258,314 B2The Wistar Institute of Anatomy and Biology
- Benzoylglycine derivatives and methods of making and using same1 Oct 2024US 12,103,904 B2Duke University
- Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulators2 Jul 2024US 12,023,333 B2Grey Wolf Therapeutics Limited
- GRP94 selective inhibitors and uses thereof26 Mar 2024US 11,939,291 B2University of Kansas
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
- Anti-viral compounds19 Mar 2026US 2026/0078094 A1INFEX Therapeutics Limited
- Anticancer polyheterocyclic compounds and associated methods18 Dec 2025US 2025/0382302 A1University of Denver
- Bismuthene as versatile photocatalyst operating under variable conditions for photoredox c-h bond functionalization13 Nov 2025US 2025/0345777 A1Koc Universitesi
Most cited
By later US patents
- N-aroylamino acid amides as endothelin inhibitors91US 5,977,075 ANovartis AG · 1999
- Insecticidal N'-substituted-N,N'-diacylhydrazines83US 4,985,461 ARohm and Haas Company · 1991
- Polymerization process with living characteristics and polymers made therefrom75US 6,642,318 B1Commonwealth Scientific and Industrial Research Organization · 2003
- Insecticidal N' substituted-N-N'-disubstituted-hydrazines67US 5,117,057 ARohm and Haas Company · 1992
- Neprilysin inhibitors61US 8,686,184 B2Theravance, Inc. · 2014